Select Biosciences Ltd

Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals
Maxygen to contribute R&D operations and assets to newly-formed joint venture; Astellas to be granted 3-year option to acquire joint venture.

PepTcell to Start Phase Ib Clinical Trials for Novel HIV Vaccine
PepTcell’s HIV-v vaccine offers new hope in the treatment and protection of HIV as it uses a new approach for preventing and treating HIV.

TriLink Announces Sales and License Agreement with Glen Research for CleanAmp™ Amidites
Glen Research can now sell the patented CleanAmp™ Amidites to third parties for use in production of CleanAmp™ Primers.

GENEART Supports iGEM Contest for the Third Year in a Row
The iGEM contest aims at the development of standardized DNA building blocks for different applications in Synthetic Biology.

Aspects/conflicts of marine resource use – Segara Anakan – Central Java – Indonnesia
Centre of Marine Ecology (ZMT) Bremen/ Institute for Social Anthropology Freie Universität Berlin

Cultural skills that could lead to a reduction in vulnerability should be explored. This especially includes the sustainable handling of endangered nature and cultural areas as well as the prevention and treatment of catastrophes.

Study of volumetric oxygen transfer coefficient in a Taylor vortex flow bioreactor
Department of Chemical Engineering, Federal University of Sao Carlos, P.O. Box 676, Post Code 13565-905, Sao Carlos, SP, Brazil.

In biochemical processes involving cultivation of animal cells, the supply of oxygen in culture medium is an extremely important parameter in the project of bioreactors and its operation. In this work, the global volumetric transfer coefficient of oxygen (KLa) is evaluated in a Taylor vortex flow bioreactor (TVFB) and a correlation of mass transfer, of this equipment, is proposed.

Senior Director ADME
The RSA Group
Hatfield, Herts, UK

Mass Spectometry Scientist
Roswell Park Cancer Institute
Buffalo, NY, USA

Principal HTS Scientist
St. Jude Childrens Research Hospital
Memphis, TN, USA


The 2009 multi-conference in computer science, information technology, computer engineering, computational science, control and automation technology
13 July 2009 - 16 July 2009

The primary goal of the MULTICONF is to promote research and developmental activities in computer science, information technology, control engineering, and related fields.

MULTICONF-09, Orlando, Florida, USA
13 July 2009 - 16 July 2009

The primary goal of the MULTICONF is to promote research and developmental activities in computer science, information technology, control engineering, and related fields. Another goal is to promote the dissemination of research to a multidisciplinary audience and to facilitate communication among researchers, developers, practitioners in different fields.
  

A global abstract analysis of selected histone-modifying enzymes using AKS
Active Motif

A global abstract analysis (GAA) was performed on twelve histone-modifying enzymes (ASH1, CARM1, CBP, CKII, EZH2, MSK1, MST1, NSD1, PCAF, RIZ1, SIRT2 and TIP60) to demonstrate how this approach can help uncover biological relationships, scientific information, and overall publication trends from PubMed abstracts and related biological databases. This GAA study showed that published research of histone-modifying enzymes has increased significantly since 2001 and that many reported studies have fo

Multiplexed Diagnostics 2009 Market Report

Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.

Multiplexed Diagnostics 2008 Market Report

Multiplexed diagnostics are the wild west of medicine. Technology is established, regulation is limited and the number of new biomarkers exploding. First-movers are grabbing biomarker territories, combining independent measurements for efficiency and mining molecules for multivariate panels. All the while demand is high for improving diagnoses and predicting responses to treatment. The challenges, however, are uncertain reimbursement, unclear business models and ever-intensifying competition. On